Medications
Big pharma deals: Mylan raises bid for Perrigo to $35.6 bn
Generic drug company Mylan raised its bid for a second time for Perrigo on Wednesday, offering $35.6 billion for the over-the-counter giant.
Apr 29, 2015
0
1
News tagged with takeover
Other
Allergan board rebuffs latest Valeant offer (Update)
Allergan's board has unanimously rejected the latest takeover bid from Valeant Pharmaceuticals, and the Botox maker said the offer isn't even worth talking about.
Jun 10, 2014
0
0
Medications
Drugmaker Elan plans to explore sale of company (Update)
Shares of Elan Corp PLC jumped Friday after the Irish drugmaker said it will explore a possible sale of the company while its board continues to fend off a hostile takeover bid from Royalty Pharma.
Jun 14, 2013
0
0
Other
Human Genome agrees to GlaxoSmithKline takeover (Update)
(AP) — U.K. drug maker GlaxoSmithKline has secured its takeover of longtime partner Human Genome Sciences after agreeing to pay more, a move to expand GSK's drug portfolio in crucial areas: biologic drugs and treatments ...
Jul 16, 2012
0
0
Medications
Perrigo to go it alone; shareholders reject $26B Mylan bid (Update)
Shareholders of the drugmaker Perrigo shut the door on a $26-billion hostile takeover bid from Mylan.
Nov 13, 2015
0
3
Other
Royalty Pharma lets Elan takeover bid expire
Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.
Jun 18, 2013
0
0
Other
Elan moves to deter takeover bid
(AP)—Irish drug maker Elan Corp. announced Monday it will pay shareholders a recurring special dividend linked to the sales of the multiple sclerosis treatment Tysabri.
Mar 4, 2013
0
0
Other
Judge halts Royalty Pharma's bid for Elan stock
Irish drugmaker Elan Corp.'s fight against a takeover bid by Royalty Pharma has spilled into U.S. federal court, where a judge has issued a temporary restraining order preventing Royalty from completing its offer to buy the ...
Jun 4, 2013
0
0
Other
Valeant Pharma expects 3Q revenue to top forecasts
Shares of Valeant Pharmaceuticals International Inc. climbed Wednesday after the Canadian drugmaker said it expects market share gains in most of its businesses and that its third-quarter revenue will top forecasts.
Sep 24, 2014
0
0
Other
Elan holders OK buyback, vote down three deals (Update)
Shareholders of Irish drugmaker Elan Corp. PLC have potentially ended a takeover bid from Royalty Pharma by voting in favor of an Elan share buyback plan.
Jun 17, 2013
0
0
